medigraphic.com
ISSN 1029-3019 (Electronic)

2013, Number 04

<< Back Next >>

MediSan 2013; 17 (04)

Characterization of patients with hypertension in

Guerra CE, Vázquez TJM, Dominica EY, Hinojosa RY, Chang FA

Language: Spanish
References: 17
Page: 599-604
PDF size: 70.95 Kb.


ABSTRACT

A descriptive, longitudinal and prospective study was conducted in 2 401 patients with hypertension, belonging to the health area of "Ramón López Peña" University Polyclinic of Santiago de Cuba, from January 2010 to the same month of 2012, in order to characterize them according to clinical and epidemiological variates of interest. In the series a high incidence of this condition in adolescents and a high prevalence in the fourth and fifth decades of life were found, especially in those who had family medical history of the disease and associated risk factors. Complications appeared after 10 years of clinical course in those with uncontrolled condition, attributable mainly to the discontinuation of treatment and/or misuse of drugs, mostly consisting in thiazide diuretics and inhibitors of the angiotensin converting enzyme in addition to the limited use of non-pharmacological drugs. It is imposed to continue insisting on health education related to this chronic non-communicable disease in primary health care.


REFERENCES

  1. Comisión Nacional Técnica Asesora del Programa de Hipertensión Arterial: Hipertensión Arterial. Guía para la prevención, diagnóstico y tratamiento. La Habana: Editorial Ciencias Médicas; 2008.

  2. Castillo Álvarez YC, Chávez Vega R, Alfonzo Guerra JP. Incidencia y prevalencia de hipertensión arterial registrada en el día mundial de la lucha contra la Hipertensión Arterial. Experiencia de un grupo de trabajo. Rev Cubana Med. 2011 [citado 9 Abr 2012]; 50(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232011000300002

  3. Pérez Caballero MD, León Álvarez JL, Fernández Arias MA. El control de la hipertensión arterial: un problema no resuelto. Rev Cubana Medicina. 2011 [citado 9 Abr 2012]; 50(3). Disponible en: http://www.bvs.sld.cu/revistas/med/vol50_03_11/med09311.htm

  4. Armano P, SeguraJ, Vigel L, Parody E, Rulote LM. Factores y causas de mal control y estrategia de corresponsabilidad médico paciente en el control de la hipertensión. Rev Cubana Med. 2007; 24(3):93-100.

  5. European Society of Hypertension and the European Society of Cardiology Guidelines for Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension. J Hypertens. 2007; 25: 1105-87.

  6. Schargrodsky H, Hernandez R, Champagne BM, Silva H, Vinueza R, Silva Aycaguer LC. Assessment of cardiovascular risk in seven Latin American cities. Am J Med. 2008; 121: 58-65.

  7. Julius S, Kaciroti N, Egan BM, Nesbitt S, Michelson EL. Trial of Preventing Hypertension (TROPHY) Investigators. J Am Soc Hypertens. 2008; 2(1):39-43.

  8. Llibre Rodríguez J, Laucerique Pardo T, Noriega Fernández L, Guerra Hernández L. Prevalencia de hipertensión arterial, adhesión al tratamiento y su control en adultos mayores. Rev Cubana Med. 2011 [citado 9 Abr 2012]; 50(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232011000300003

  9. Díaz A, Tringler M, Molina JD, Díaz MC, Geromini V, Aguera D, et al. Control de la presión arterial en niños y adolescentes de una población rural de Argentina. Datos preliminares del Proyecto Vela. Ach Argent Pediatr. 2010; 108:68-74.

  10. Marrodán Serrano D, Cabañas Armesilla D, Carmenate Moreno M, González Montero de Espinosa M, López Ejeda N, Martínez Álvarez JR, et al. Asociación entre adiposidad corporal y presión arterial entre los 6 y los 16 años. Análisis en una población escolar madrileña. Rev Esp Cardiol. 2013; 66(2): 110-5.

  11. Román AO, Badilla SM, Dussaubat AM. Hypertension as a biological marker of systemic atherosclerotic disease. J Med. 2010; 138(3):346-51.

  12. John J, Muliyil J, Balraj V. Screening for hypertension among older adults: a primary care “high risk” approach. Indian J Community Med. 2010; 35(1):67-9.

  13. Hansson L, Hedner T, Lund Johansen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, et al. Randomized trial of effects of calcium antagonist compared with diuretics and ßblockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet. 2000; 356(9227):359-65.

  14. Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomized to double-blind treatment with long-acting calcium-channel blocker or diuretic in the International Nifedipino GITS study: intervention as a goal in hypertension treatment (INSIGHT), 356; Lancet. 2000:366-372.

  15. Alfonzo Guerra JP. Prehipertensión: mito o realidad. Rev Cubana Med. 2011 [citado 9 Abr 2012]; 50(3). Disponible en: http://www.bvs.sld.cu/revistas/med/vol50_03_11/med07311.htm

  16. Cuba, Ministerio de Salud Pública. Anuario Estadístico. Ministerio de Salud Pública. La Habana: MINSAP; 2010 [citado 12 Ago 2012]. Disponible en: http://files.sld.cu/dne/files/2012/04/anuario-2011-e.pdf

  17. Khan BH, Emmelgarn NA, Herman RJ, Bell ChM, Mahon JL. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2-therapy. Canadian J Cardiol. 2009; 25(5):287-98.




2020     |     www.medigraphic.com